Skip to main content
. Author manuscript; available in PMC: 2019 Nov 29.
Published in final edited form as: Cell. 2018 Nov 29;175(6):1546–1560.e17. doi: 10.1016/j.cell.2018.09.041

Figure 2. Formation of the Same Unusual Folate Metabolite upon Methotrexate Treatment.

Figure 2

(A) HPLC analysis of folates from MDA-MB-468 cells, untreated or treated with 1 μM methotrexate for indicated times.

(B) Western blot analysis of 293T parental, DHFR-knockout, DHFR-DHFRL1-double-knockout, and DHFR-TYMS-double-knockout cells.

(C) HPLC analysis of folates from 293T parental, DHFR-knockout, DHFR-DHFRL1-double-knockout cells, untreated or treated with 1 μM methotrexate for 24 hr. 100 μM hypoxanthine and 16 μM thymidine (HT) were included in the medium to support cell growth.

(D) HPLC analysis of folates from 293T DHFR-TYMS-double-knockout cells.

(E) HPLC analysis of folates from MDA-MB-468 TYMS-knockout cells, untreated or treated with 1 μM methotrexate for 6 hr. 16 μM thymidine was included in the medium to support cell growth.

See also Figure S2.